The COVID-19 IgG/IgM (Whole Blood/Serum/Plasma) Rapid Test Device utilizes lateral flow technology that is used for the qualitative, differential detection of both anti- SARS-CoV-2 IgM and IgG antibodies. In general, antibodies can be detected 1-3 weeks after infection. This test is intended to screen patients for COVID-19. Combining RNA and Antibody tests can significantly raise the sensitivity for detecting COVID-19 in infected individuals.

Origin: US, Wait Time: 1-2 Weeks, Minimum Order Quantity: 10K

Terms are prepaid unless otherwise indicated or determined on a case by case basis. Financing is available for most products.

Inquire for distributor and government pricing